Essentia Analytics Announces Two Key Appointments

Two key appointments boost Essentia's growth

greg-wallace-essentia
Essentia embarks on "new phase of rapid growth" with appointment of Greg Wallace.

Greg Wallace, formerly equities and quant specialist and founder of EQ International, joins Essentia as head of research, while James Ramirez, formerly of Barclays Wealth and Investment Management, joins as the firm's CTO.

With over 25 years' experience in the Australian investment market, Wallace will focus on delivering valuable, actionable insights to end-users, from illustrations of behavioural biases, to investment process analytics.

As winner of the 2014 Best Data Analytics category in the Buy-Side Technology Awards, Essentia is worth keeping an eye on over the coming months, given that the firm has embarked on a phase of rapid growth in a sector likely to garner significant interest from the buy side as asset managers look to systematize the processes around their decision support.  

"Essentia has reached a new phase of rapid growth, and James and Greg are just the people to take us forward, says Clare Flynn Levy, founder and CEO of Essentia.

"James brings to Essentia entrepreneurial thinking combined with best-practice professional standards and vast experience in building and leading global financial technology teams. Greg combines a great amount of experience and influence in the investment world with knowledge of what it really takes to improve performance and processes," she adds.

 

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here